BICTEGRAVIR, (13AS)-
UNII H4U2B6Q5QJ

Substance Identification & Data

This profile provides standardized clinical and technical data for Bictegravir, (13as)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) H4U2B6Q5QJ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
H4U2B6Q5QJ
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
BICTEGRAVIR, (13AS)-
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C21H18F3N3O5
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
SOLUWJRYJLAZCX-USBNGQNGSA-N
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
146300638
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
[C@]12(N(C(c3n(C1)cc(c(c3O)=O)C(NCc4c(cc(cc4F)F)F)=O)=O)[C@H]5CC[C@@H](O2)C5)[H]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Bictegravir, (13as)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

BICTEGRAVIR IMPURITY 10(2R,5S,13AS)
BICTEGRAVIR, (13AS)-

Systematic Nomenclature

(2R,5S,13AS)-2,3,4,5,7,9,13,13A-OCTAHYDRO-8-HYDROXY-7,9-DIOXO-N-((2,4,6-TRIFLUOROPHENYL)METHYL)-2,5-METHANOPYRIDO(1',2':4,5)PYRAZINO(2,1-B)(1,3)OXAZEPINE-10-CARBOXAMIDE
2,5-METHANOPYRIDO(1',2':4,5)PYRAZINO(2,1-B)(1,3)OXAZEPINE-10-CARBOXAMIDE, 2,3,4,5,7,9,13,13A-OCTAHYDRO-8-HYDROXY-7,9-DIOXO-N-((2,4,6-TRIFLUOROPHENYL)METHYL)-, (2R,5S,13AS)-

External Clinical & Regulatory Resources

NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NLM
PubChem Compound